writteninfo.com

It seems that most industries are rushing to jump aboard the Twitter bandwagon.
That’s true for most cases, with the pharmaceutical industry being the exception.
David Williams points out the lack of Twitter activity from the major pharmaceutical companies, where many of the Pharma-related keywords being owned by those not affiliated with the company.
Worse, when he looks [...]

GlaxoSmithKline Consumer Healthcare, makers of alli, the only FDA-approved over-the-counter weight loss product, supports the U.S. Food and Drug Administration (FDA) seeking a recall of weight loss products that pose serious health risks, particularly during this New Year’s period, when many people…
[[ This is a content summary only. Visit my website for full links, other [...]

The FDA versus Cheeros furor is getting some blogosphere play.
Internist Matthew Mintz analyzes the claim that Cheerios lowers cholesterol by 4 percent. Big deal, he says. “The problem is that even though Cheerios may lower your cholesterol by 4 percent, this probably has no impact on your risk for heart attack or stroke [...]

It’s been one thing after the next since Daiichi Sankyo’s deal last year for control of Indian generics maker Ranbaxy, including the FDA’s banning imports from certain Ranbaxy plants and accusing the company of falsifying data.
The news over the weekend that Ranbaxy CEO Malvinder Mohan Singh (pictured) was resigning has spurred optimism that Daiichi might [...]

Johnson & Johnson said late yesterday that it’s buying Cougar Biotechnology for about $894 million, or $43 a share. That’s a 16% premium to where the stock closed yesterday. Including Cougar’s cash on hand, the deal’s value is about $970 million.
Cougar’s lead product is an experimental drug called abiraterone, which is in late-stage trials for [...]

Those keeping score at home can cross one more job off the list of long-unfilled federal health positions: By a voice vote, the Senate yesterday confirmed Margaret “Peggy” Hamburg to lead the FDA.
It’s been pretty clear for a while that the Senate would greenlight Hamburg for the job; some key Republicans piped up in her [...]

It’s been a tough week for Botox. First, the FDA approved a competitor drug called Dysport. Then the agency said both drugs, along with a third called Myobloc, should carry black-box warnings to alert patients and doctors to serious safety risks. Here’s the “early communication” the FDA released yesterday on Botox and Myobloc.
All three drugs [...]

After its stock fell off a cliff yesterday only to soar back later, Dendreon is looking no worse for wear today. In fact, it was looking all the better to some on Wall Street as a potential takeover target.
Analysts are focusing on study data for its new prostate cancer treatment Provenge rather than the latest [...]

Dendreon’s gyrations continue: The biotech company’s shares surged this morning after a sudden plunge yesterday as Dendreon was to about to announce details of its latest Provenge study.
The share price more than doubled to $25.42 in morning trading. This comes after the shares’ roller-coaster ride yesterday, in which they hit a 52-week high of $25, [...]

If you are currently taking a weight loss supplement or are considering doing so as part of a “New Year’s Resolution” to loss weight, RECONSIDER.
The U.S. Food and Drug Administration has just released a list of more than 25 different products marketed for weight loss that should not be used. The…
[[ This is a content [...]